Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1117745

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1117745

Global At-Home Drug of Abuse (DOA) Testing Market Insights, Forecast to 2028

PUBLISHED:
PAGES: 106 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the At-Home Drug of Abuse (DOA) Testing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Test Cups
    • 1.2.3 Test Dip Cards
    • 1.2.4 Test Strips
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Urine
    • 1.3.3 Saliva
    • 1.3.4 Hair
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2017-2028)
  • 2.2 At-Home Drug of Abuse (DOA) Testing Growth Trends by Region
    • 2.2.1 At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Size by Region (2017-2022)
    • 2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 At-Home Drug of Abuse (DOA) Testing Market Dynamics
    • 2.3.1 At-Home Drug of Abuse (DOA) Testing Industry Trends
    • 2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
    • 2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
    • 2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue
    • 3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2017-2022)
    • 3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
  • 3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
    • 3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2021
  • 3.5 At-Home Drug of Abuse (DOA) Testing Key Players Head office and Area Served
  • 3.6 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
  • 3.7 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type

  • 4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2017-2022)
  • 4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2023-2028)

5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application

  • 5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2017-2022)
  • 5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 6.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 6.2.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 6.2.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 6.2.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 6.3.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 6.3.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 6.3.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country
    • 6.4.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
    • 6.4.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 7.2.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 7.2.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 7.2.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 7.3.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 7.3.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country
    • 7.4.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
    • 7.4.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 8.2.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 8.3.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region
    • 8.4.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 9.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 9.2.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 9.2.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 9.2.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 9.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 9.3.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 9.3.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 9.3.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 9.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country
    • 9.4.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
    • 9.4.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 10.2.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 10.3.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country
    • 10.4.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 UCP Biosciences
    • 11.1.1 UCP Biosciences Company Details
    • 11.1.2 UCP Biosciences Business Overview
    • 11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.1.5 UCP Biosciences Recent Developments
  • 11.2 Orient New Life Medical
    • 11.2.1 Orient New Life Medical Company Details
    • 11.2.2 Orient New Life Medical Business Overview
    • 11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.2.5 Orient New Life Medical Recent Developments
  • 11.3 Express Diagnostics Int'l
    • 11.3.1 Express Diagnostics Int'l Company Details
    • 11.3.2 Express Diagnostics Int'l Business Overview
    • 11.3.3 Express Diagnostics Int'l At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.3.4 Express Diagnostics Int'l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.3.5 Express Diagnostics Int'l Recent Developments
  • 11.4 Assure Tech (Hangzhou)
    • 11.4.1 Assure Tech (Hangzhou) Company Details
    • 11.4.2 Assure Tech (Hangzhou) Business Overview
    • 11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.4.5 Assure Tech (Hangzhou) Recent Developments
  • 11.5 Psychemedics Corporation
    • 11.5.1 Psychemedics Corporation Company Details
    • 11.5.2 Psychemedics Corporation Business Overview
    • 11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.5.5 Psychemedics Corporation Recent Developments
  • 11.6 Confirm BioSciences
    • 11.6.1 Confirm BioSciences Company Details
    • 11.6.2 Confirm BioSciences Business Overview
    • 11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.6.5 Confirm BioSciences Recent Developments
  • 11.7 Phamatech
    • 11.7.1 Phamatech Company Details
    • 11.7.2 Phamatech Business Overview
    • 11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.7.5 Phamatech Recent Developments
  • 11.8 Home Health (U.K.) Ltd.
    • 11.8.1 Home Health (U.K.) Ltd. Company Details
    • 11.8.2 Home Health (U.K.) Ltd. Business Overview
    • 11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.8.5 Home Health (U.K.) Ltd. Recent Developments
  • 11.9 Quest Products
    • 11.9.1 Quest Products Company Details
    • 11.9.2 Quest Products Business Overview
    • 11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.9.5 Quest Products Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Test Cups
    • 1.2.3 Test Dip Cards
    • 1.2.4 Test Strips
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Urine
    • 1.3.3 Saliva
    • 1.3.4 Hair
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2017-2028)
  • 2.2 At-Home Drug of Abuse (DOA) Testing Growth Trends by Region
    • 2.2.1 At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Size by Region (2017-2022)
    • 2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 At-Home Drug of Abuse (DOA) Testing Market Dynamics
    • 2.3.1 At-Home Drug of Abuse (DOA) Testing Industry Trends
    • 2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
    • 2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
    • 2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue
    • 3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2017-2022)
    • 3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
  • 3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
    • 3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2021
  • 3.5 At-Home Drug of Abuse (DOA) Testing Key Players Head office and Area Served
  • 3.6 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
  • 3.7 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type

  • 4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2017-2022)
  • 4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2023-2028)

5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application

  • 5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2017-2022)
  • 5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 6.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 6.2.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 6.2.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 6.2.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 6.3.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 6.3.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 6.3.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country
    • 6.4.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
    • 6.4.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 7.2.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 7.2.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 7.2.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 7.3.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 7.3.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country
    • 7.4.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
    • 7.4.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 8.2.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 8.3.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region
    • 8.4.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 9.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 9.2.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 9.2.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 9.2.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 9.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 9.3.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 9.3.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 9.3.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 9.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country
    • 9.4.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
    • 9.4.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)
  • 10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type
    • 10.2.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application
    • 10.3.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country
    • 10.4.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 UCP Biosciences
    • 11.1.1 UCP Biosciences Company Details
    • 11.1.2 UCP Biosciences Business Overview
    • 11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.1.5 UCP Biosciences Recent Developments
  • 11.2 Orient New Life Medical
    • 11.2.1 Orient New Life Medical Company Details
    • 11.2.2 Orient New Life Medical Business Overview
    • 11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.2.5 Orient New Life Medical Recent Developments
  • 11.3 Express Diagnostics Int'l
    • 11.3.1 Express Diagnostics Int'l Company Details
    • 11.3.2 Express Diagnostics Int'l Business Overview
    • 11.3.3 Express Diagnostics Int'l At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.3.4 Express Diagnostics Int'l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.3.5 Express Diagnostics Int'l Recent Developments
  • 11.4 Assure Tech (Hangzhou)
    • 11.4.1 Assure Tech (Hangzhou) Company Details
    • 11.4.2 Assure Tech (Hangzhou) Business Overview
    • 11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.4.5 Assure Tech (Hangzhou) Recent Developments
  • 11.5 Psychemedics Corporation
    • 11.5.1 Psychemedics Corporation Company Details
    • 11.5.2 Psychemedics Corporation Business Overview
    • 11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.5.5 Psychemedics Corporation Recent Developments
  • 11.6 Confirm BioSciences
    • 11.6.1 Confirm BioSciences Company Details
    • 11.6.2 Confirm BioSciences Business Overview
    • 11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.6.5 Confirm BioSciences Recent Developments
  • 11.7 Phamatech
    • 11.7.1 Phamatech Company Details
    • 11.7.2 Phamatech Business Overview
    • 11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.7.5 Phamatech Recent Developments
  • 11.8 Home Health (U.K.) Ltd.
    • 11.8.1 Home Health (U.K.) Ltd. Company Details
    • 11.8.2 Home Health (U.K.) Ltd. Business Overview
    • 11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.8.5 Home Health (U.K.) Ltd. Recent Developments
  • 11.9 Quest Products
    • 11.9.1 Quest Products Company Details
    • 11.9.2 Quest Products Business Overview
    • 11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
    • 11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
    • 11.9.5 Quest Products Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
  • Table 1. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Test Cups
  • Table 3. Key Players of Test Dip Cards
  • Table 4. Key Players of Test Strips
  • Table 5. Key Players of Others
  • Table 6. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2017-2022)
  • Table 10. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2023-2028)
  • Table 12. At-Home Drug of Abuse (DOA) Testing Market Trends
  • Table 13. At-Home Drug of Abuse (DOA) Testing Market Drivers
  • Table 14. At-Home Drug of Abuse (DOA) Testing Market Challenges
  • Table 15. At-Home Drug of Abuse (DOA) Testing Market Restraints
  • Table 16. Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Players (2017-2022)
  • Table 18. Global Top At-Home Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2021)
  • Table 19. Ranking of Global Top At-Home Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
  • Table 23. Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2017-2022)
  • Table 27. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2023-2028)
  • Table 29. Global At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Application (2017-2022)
  • Table 31. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Application (2023-2028)
  • Table 33. North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. UCP Biosciences Company Details
  • Table 64. UCP Biosciences Business Overview
  • Table 65. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product
  • Table 66. UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
  • Table 67. UCP Biosciences Recent Developments
  • Table 68. Orient New Life Medical Company Details
  • Table 69. Orient New Life Medical Business Overview
  • Table 70. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product
  • Table 71. Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
  • Table 72. Orient New Life Medical Recent Developments
  • Table 73. Express Diagnostics Int'l Company Details
  • Table 74. Express Diagnostics Int'l Business Overview
  • Table 75. Express Diagnostics Int'l At-Home Drug of Abuse (DOA) Testing Product
  • Table 76. Express Diagnostics Int'l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
  • Table 77. Express Diagnostics Int'l Recent Developments
  • Table 78. Assure Tech (Hangzhou) Company Details
  • Table 79. Assure Tech (Hangzhou) Business Overview
  • Table 80. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product
  • Table 81. Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
  • Table 82. Assure Tech (Hangzhou) Recent Developments
  • Table 83. Psychemedics Corporation Company Details
  • Table 84. Psychemedics Corporation Business Overview
  • Table 85. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product
  • Table 86. Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
  • Table 87. Psychemedics Corporation Recent Developments
  • Table 88. Confirm BioSciences Company Details
  • Table 89. Confirm BioSciences Business Overview
  • Table 90. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product
  • Table 91. Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
  • Table 92. Confirm BioSciences Recent Developments
  • Table 93. Phamatech Company Details
  • Table 94. Phamatech Business Overview
  • Table 95. Phamatech At-Home Drug of Abuse (DOA) Testing Product
  • Table 96. Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
  • Table 97. Phamatech Recent Developments
  • Table 98. Home Health (U.K.) Ltd. Company Details
  • Table 99. Home Health (U.K.) Ltd. Business Overview
  • Table 100. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product
  • Table 101. Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
  • Table 102. Home Health (U.K.) Ltd. Recent Developments
  • Table 103. Quest Products Company Details
  • Table 104. Quest Products Business Overview
  • Table 105. Quest Products At-Home Drug of Abuse (DOA) Testing Product
  • Table 106. Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
  • Table 107. Quest Products Recent Developments
  • Table 108. Research Programs/Design for This Report
  • Table 109. Key Data Information from Secondary Sources
  • Table 110. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global At-Home Drug of Abuse (DOA) Testing Market Share by Type: 2021 VS 2028
  • Figure 2. Test Cups Features
  • Figure 3. Test Dip Cards Features
  • Figure 4. Test Strips Features
  • Figure 5. Others Features
  • Figure 6. Global At-Home Drug of Abuse (DOA) Testing Market Share by Application: 2021 VS 2028
  • Figure 7. Urine Case Studies
  • Figure 8. Saliva Case Studies
  • Figure 9. Hair Case Studies
  • Figure 10. Others Case Studies
  • Figure 11. At-Home Drug of Abuse (DOA) Testing Report Years Considered
  • Figure 12. Global At-Home Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 13. Global At-Home Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region: 2021 VS 2028
  • Figure 15. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players in 2021
  • Figure 16. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2021)
  • Figure 17. The Top 10 and 5 Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue in 2021
  • Figure 18. North America At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 19. North America At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
  • Figure 20. North America At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
  • Figure 21. North America At-Home Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)
  • Figure 22. United States At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Canada At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 25. Europe At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
  • Figure 26. Europe At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
  • Figure 27. Europe At-Home Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)
  • Figure 28. Germany At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. France At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. U.K. At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Italy At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Russia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Nordic Countries At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 35. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
  • Figure 36. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
  • Figure 37. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size Share by Region (2017-2028)
  • Figure 38. China At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South Korea At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 44. Latin America At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 45. Latin America At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
  • Figure 46. Latin America At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
  • Figure 47. Latin America At-Home Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)
  • Figure 48. Mexico At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Brazil At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 51. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
  • Figure 52. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
  • Figure 53. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)
  • Figure 54. Turkey At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. UAE At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. South Africa At-Home Drug of Abuse (DOA) Testing Revenue (2017-2028) & (US$ Million)
  • Figure 58. UCP Biosciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
  • Figure 59. Orient New Life Medical Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
  • Figure 60. Express Diagnostics Int'l Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
  • Figure 61. Assure Tech (Hangzhou) Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
  • Figure 62. Psychemedics Corporation Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
  • Figure 63. Confirm BioSciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
  • Figure 64. Phamatech Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
  • Figure 65. Home Health (U.K.) Ltd. Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
  • Figure 66. Quest Products Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)
  • Figure 67. Bottom-up and Top-down Approaches for This Report
  • Figure 68. Data Triangulation
  • Figure 69. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!